a randomized, double-blind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis:一项随机,双盲,加替沙星与复杂性尿路感染、肾盂肾炎的治疗的多中心比较环丙沙星.pdfVIP

a randomized, double-blind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis:一项随机,双盲,加替沙星与复杂性尿路感染、肾盂肾炎的治疗的多中心比较环丙沙星.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
a randomized, double-blind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis:一项随机,双盲,加替沙星与复杂性尿路感染、肾盂肾炎的治疗的多中心比较环丙沙星

CLINICAL THERAPEUTICS®/VOL.24, NO. 2, 2002 A Randomized, Double-Blind, Multicenter Comparison of Gatifloxacin Versus Ciprofloxacin in the Treatment of Complicated Urinary Tract Infection and Pyelonephritis Clair E. Cox, MD, 1 Thomas C. Marbury, AID, z Walter G. Pittman, MD, 3 Gary L. Brown, AID, 4 Stephen M. Auerbach, MD, s Barry C. Fox, MD, 6 and Joanna Y. Yang, PhD 7 1Universityof Tennessee,Memphis, Tennessee,2Orlando ClinicalResearch Center, Orlando, Florida, 3LloydNolan UrologyCenter,Fairfield,Alabama, 4pharmaTex Research, Amarillo, Texas,5CaliforniaProfessionalResearch, Newport Coast, California, 6Dean Clinic,Madison, Wisconsin,and 7Bristol-MyersSquibb Company, Wallingford, Connecticut ABSTRACT Background: Gatifloxacin is a fluoroquinolone antibiotic with a broad spectrum of in vitro and in vivo activity against the gram-negative and gram-positive pathogens fre- quently implicated in urinary tract infections (UTIs). Objective: This study compared the clinical and bacteriologic efficacy and tolerability of gatifloxacin versus ciprofloxacin in adult patients with complicated UTIs or pyelonephritis. Methods: In this double-blind, multicenter, randomized, comparative study, patients were treated with either gatifloxacin 400 mg once daily or ciprofloxacin 500 mg twice daily for 7 to 10 days. Bacteriologic eradication (by quantitative urine culture) and clin- ical efficacy rates were assessed at a test-of-cure visit (5 to 9 days and 4 to 11 days post- treatment, respectively) and at an extended follow-up visit (29-42 days and 25-50 days posttreatment, respectively). Results: A total of 372 adults were randomized to treatment, 189 to gatifloxacin and 183 to ciprofloxacin. The most commo

您可能关注的文档

文档评论(0)

ajgoaw + 关注
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档